Acute exacerbation among chronic hepatitis C patients: tip of the iceberg that deserves more attention.
作者信息
Wong Robert J, Cheung Ramsey C
出版信息
Clin Gastroenterol Hepatol. 2013 Sep;11(9):1181-2. doi: 10.1016/j.cgh.2013.05.023. Epub 2013 Jun 2.
PMID:23735449
Abstract
摘要
相似文献
1
Acute exacerbation among chronic hepatitis C patients: tip of the iceberg that deserves more attention.慢性丙型肝炎患者的急性加重：值得更多关注的冰山一角。
Clin Gastroenterol Hepatol. 2013 Sep;11(9):1181-2. doi: 10.1016/j.cgh.2013.05.023. Epub 2013 Jun 2.
2
The multifaceted functions of ribavirin: antiviral, immunomodulator, or both?利巴韦林的多方面功能：抗病毒、免疫调节，还是两者兼具？
Hepatology. 2014 Oct;60(4):1126-9. doi: 10.1002/hep.27186. Epub 2014 Jun 26.
3
A view to natural killer cells in hepatitis C.丙型肝炎中的自然杀伤细胞研究视角。
Gastroenterology. 2011 Oct;141(4):1144-8. doi: 10.1053/j.gastro.2011.08.025. Epub 2011 Aug 27.
4
Scleromyxedema secondary to hepatitis C virus and successfully treated with antiviral therapy.
Dermatol Online J. 2015 Sep 17;21(9):13030/qt1vt8c3vt.
5
The end of the beginning for hepatitis C treatment.
Hepatology. 2012 Mar;55(3):664-5. doi: 10.1002/hep.25528.
6
PegIFN/ribavirin during acute HCV coinfection.急性丙型肝炎病毒合并感染时的聚乙二醇干扰素/利巴韦林
IAPAC Mon. 2004 Jul;10(7):260-1.
7
Sofosbuvir, pegylated interferon, and ribavirin for retreatment of hepatitis C virus genotype 1b following sofosbuvir and ledipasvir failure.索磷布韦、聚乙二醇干扰素和利巴韦林用于索磷布韦和来迪帕司韦治疗失败后的丙型肝炎病毒1b型再治疗。
Hepatology. 2018 May;67(5):2049-2050. doi: 10.1002/hep.29667. Epub 2018 Mar 25.
8
Seventy-two weeks of peginterferon and ribavirin for patients with partial early virologic response?
Hepatology. 2007 Dec;46(6):1671-4. doi: 10.1002/hep.22030.
9
Pegylated interferon and ribavirin in real life: efficacy versus effectiveness.
Hepatology. 2010 Nov;52(5):1867. doi: 10.1002/hep.23824.
10
[Treatment with pegylated interferon and ribavirin in patients co-infected by human immunodeficiency virus and hepatitis C virus].[聚乙二醇干扰素和利巴韦林治疗人类免疫缺陷病毒与丙型肝炎病毒合并感染患者]
Rev Clin Esp. 2007 Mar;207(3):150-1; author reply 151-2.
Zotero 插件